✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Prevest Denpro Ltd.

PREVEST

Market Cap
₹621 Cr.
P/E
34.93

Prevest Denpro Ltd.

  • Prevest Denpro
  • Medicamen Biotech
  • Sakar Healthcare
  • TJI Pharma - Small Cap
FAQs on Prevest Denpro Ltd. Shareprice

Prevest Denpro has given lower returns compared to its competitors.
Prevest Denpro has grown at ~10.7% over the last 3yrs while peers have grown at a median rate of 21.18%

Prevest Denpro is not expensive.
Latest PE of Prevest Denpro is 34.93, while 3 year average PE is 38.38.
Also latest EV/EBITDA of Prevest Denpro is 26.24 while 3yr average is 31.98.

View FAQ's On Business
Growth Table
  • Prevest Denpro Ltd.
  • Medicamen Biotech
  • Sakar Healthcare
Balance Sheet
  • Prevest Denpro Ltd.
  • Medicamen Biotech
  • Sakar Healthcare
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Prevest Denpro Ltd.
  • Medicamen Biotech
  • Sakar Healthcare
Cash Flow
  • Prevest Denpro Ltd.
  • Medicamen Biotech
  • Sakar Healthcare
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Prevest Denpro Ltd.
  • Medicamen Biotech
  • Sakar Healthcare
Quarterly Results
  • Prevest Denpro Ltd.
  • Medicamen Biotech
  • Sakar Healthcare
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Prevest Denpro Ltd. Financials

Balance sheet of Prevest Denpro is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Prevest Denpro is increasing.
Latest debt of Prevest Denpro is -₹55.95 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹97.06 Crs.

Yes, profit is increasing.
The profit of Prevest Denpro is ₹17.79 Crs for TTM, ₹16.14 Crs for Mar 2024 and ₹15.71 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Prevest Denpro latest dividend payout ratio is 7.44% and 3yr average dividend payout ratio is 7.54%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech